{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:37:05Z","timestamp":1790638625897,"version":"4.1.0"},"reference-count":50,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Serbian Ministry of Science","award":["451-03-47\/2023-01\/200111"],"award-info":[{"award-number":["451-03-47\/2023-01\/200111"]}]},{"name":"Serbian Ministry of Science","award":["MP01\/18"],"award-info":[{"award-number":["MP01\/18"]}]},{"name":"Faculty of Medical Sciences University of Kragujevac","award":["451-03-47\/2023-01\/200111"],"award-info":[{"award-number":["451-03-47\/2023-01\/200111"]}]},{"name":"Faculty of Medical Sciences University of Kragujevac","award":["MP01\/18"],"award-info":[{"award-number":["MP01\/18"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder characterized by the gradual loss of dopamine-producing neurons. Oxidative stress, mitochondrial dysfunction, detrimental immune response, and neuroinflammation are mainly responsible for the injury and degeneration of dopaminergic neurons in the brains of patients suffering from PD. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as a promising therapeutic approach for treating PD due to their ability to suppress the activation of inflammatory immune cells and enhance the viability and function of dopamine-producing neurons. MSC-EVs can easily bypass the blood-brain barrier and deliver their cargo (neuroprotective factors, immunosuppressive proteins, and microRNAs) to injured dopamine-producing neurons and brain-infiltrated inflammatory immune cells. A large number of recently published experimental studies demonstrated that MSC-EVs efficiently alleviated PD-related motor and behavioral deficits in animal models, indicating that MSC-EVs should be considered as potentially new therapeutic agents for the treatment of PD. Accordingly, in this review article, we summarized current knowledge about the therapeutic potential of MSCs-EVs in the treatment of PD, paving the way for their future clinical use in the treatment of neurodegenerative and neuroinflammatory disorders.<\/jats:p>","DOI":"10.3390\/cells14080600","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T04:05:31Z","timestamp":1744776331000},"page":"600","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Treatment of Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"14","author":[{"given":"Ana","family":"Volarevic","sequence":"first","affiliation":[{"name":"Departments of Psychology, Center for Research on Harmful Effects of Biological and Chemical Hazards, Faculty of Medical Sciences University of Kragujevac, 69 Svetozara Markovica Street, 34000 Kragujevac, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5906-9198","authenticated-orcid":false,"given":"Carl Randall","family":"Harrell","sequence":"additional","affiliation":[{"name":"Regenerative Processing Plant, LLC, 34176 US Highway 19 N, Palm Harbor, FL 34684, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2742-8165","authenticated-orcid":false,"given":"Aleksandar","family":"Arsenijevic","sequence":"additional","affiliation":[{"name":"Departments of Genetics, Microbiology and Immunology, Center for Research on Harmful Effects of Biological and Chemical Hazards, Faculty of Medical Sciences University of Kragujevac, 69 Svetozara Markovica Street, 34000 Kragujevac, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Djonov","sequence":"additional","affiliation":[{"name":"Institute of Anatomy, University of Bern, Baltzerstrasse 2, 3012 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5948-9902","authenticated-orcid":false,"given":"Vladislav","family":"Volarevic","sequence":"additional","affiliation":[{"name":"Departments of Genetics, Microbiology and Immunology, Center for Research on Harmful Effects of Biological and Chemical Hazards, Faculty of Medical Sciences University of Kragujevac, 69 Svetozara Markovica Street, 34000 Kragujevac, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","article-title":"Parkinson\u2019s Disease: A Multisystem Disorder","volume":"39","author":"Costa","year":"2023","journal-title":"Neurosci. Bull."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00702-023-02630-9","article-title":"Lewy bodies, iron, inflammation and neuromelanin: Pathological aspects underlying Parkinson\u2019s disease","volume":"130","author":"Riederer","year":"2023","journal-title":"J. Neural. Transm."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Cacabelos, R. (2017). Parkinson\u2019s Disease: From Pathogenesis to Pharmacogenomics. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18030551"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson\u2019s disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Picca, A., Calvani, R., Coelho-Junior, H.J., Landi, F., Bernabei, R., and Marzetti, E. (2020). Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration. Antioxidants, 9.","DOI":"10.3390\/antiox9080647"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Isik, S., Yeman Kiyak, B., Akbayir, R., Seyhali, R., and Arpaci, T. (2023). Microglia Mediated Neuroinflammation in Parkinson\u2019s Disease. Cells, 12.","DOI":"10.3390\/cells12071012"},{"key":"ref_8","first-page":"S65","article-title":"T Lymphocytes in Parkinson\u2019s Disease","volume":"12","author":"Contaldi","year":"2022","journal-title":"J. Park. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson\u2019s disease: What we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Pajares, M., IRojo, A., Manda, G., Bosc\u00e1, L., and Cuadrado, A. (2020). Inflammation in Parkinson\u2019s Disease: Mechanisms and Therapeutic Implications. Cells, 9.","DOI":"10.3390\/cells9071687"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson\u2019s disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrneurol.2017.128","article-title":"Long-term effects of exercise and physical therapy in people with Parkinson disease","volume":"13","author":"Mak","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref_13","first-page":"S183","article-title":"Gene Therapy for Parkinson\u2019s Disease Associated with GBA1 Mutations","volume":"11","author":"Abeliovich","year":"2021","journal-title":"J. Park. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.7150\/thno.95953","article-title":"Stem cell-derived extracellular vesicles in the therapeutic intervention of Alzheimer\u2019s Disease, Parkinson\u2019s Disease, and stroke","volume":"14","author":"Zhou","year":"2024","journal-title":"Theranostics"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Doyle, L.M., and Wang, M.Z. (2019). Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for EVsome Isolation and Analysis. Cells, 8.","DOI":"10.3390\/cells8070727"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e70027","DOI":"10.1111\/jnc.70027","article-title":"EVsome-Derived CDC42 From Hypoxia-Pretreated Neural Stem Cells Inhibits ACSL4-Related Ferroptosis to Alleviate Vascular Injury in Parkinson\u2019s Disease Mice Models","volume":"169","author":"Li","year":"2025","journal-title":"J. Neurochem."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chiang, M.C., Yang, Y.P., Nicol, C.J.B., Chiang, T., and Yen, C. (2025). Resveratrol-Enhanced Human Neural Stem Cell-Derived EVsomes Mitigate MPP+-Induced Neurotoxicity Through Activation of AMPK and Nrf2 Pathways and Inhibition of the NLRP3 Inflammasome in SH-SY5Y Cells. Life, 15.","DOI":"10.3390\/life15020294"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ji, X., Zhou, S., Wang, N., Wang, J., Wu, Y., Duan, Y., Ni, P., Zhang, J., and Yu, S. (2023). Cerebral-Organoid-Derived EVsomes Alleviate Oxidative Stress and Promote LMX1A-Dependent Dopaminergic Differentiation. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241311048"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.25259\/SNI_233_2020","article-title":"Mesenchymal stem cells in Parkinson\u2019s disease: Motor and nonmotor symptoms in the early posttransplant period","volume":"11","author":"Boika","year":"2020","journal-title":"Surg. Neurol. Int."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zaripova, L.N., Midgley, A., Christmas, S.E., Beresford, M.W., Pain, C., Baildam, E.M., and Oldershaw, R.A. (2023). Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216040"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/ijms.21666","article-title":"Ethical and Safety Issues of Stem Cell-Based Therapy","volume":"15","author":"Volarevic","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s13287-022-03050-4","article-title":"The potential use of mesenchymal stem cells and their EVsomes in Parkinson\u2019s disease treatment","volume":"13","author":"Heris","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Harrell, C.R., Volarevic, A., Djonov, V., and Volarevic, V. (2021). Mesenchymal Stem Cell-Derived EVsomes as New Remedy for the Treatment of Neurocognitive Disorders. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031433"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Liu, S.F., Li, L.Y., Zhuang, J.L., Li, M.M., Ye, L.C., Chen, X.R., Lin, S., and Chen, C.N. (2022). Update on the application of mesenchymal stem cell-derived EVsomes in the treatment of Parkinson\u2019s disease: A systematic review. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.950715"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s10072-023-06706-y","article-title":"The role of EVsomes in pathogenesis and the therapeutic efficacy of mesenchymal stem cell-derived EVsomes against Parkinson\u2019s disease","volume":"44","author":"Abrishamdar","year":"2023","journal-title":"Neurol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"d\u2019Angelo, M., Cimini, A., and Castelli, V. (2020). Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson\u2019s Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155241"},{"key":"ref_27","first-page":"16","article-title":"Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access","volume":"29","author":"Giovannelli","year":"2023","journal-title":"Bioact. Mater."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuroscience.2024.04.010","article-title":"Intranasal Administration of Umbilical Cord Mesenchymal Stem Cell EVsomes Alleviates Parkinson\u2019s Disease","volume":"549","author":"Huang","year":"2024","journal-title":"Neuroscience"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4103\/1673-5374.368300","article-title":"EVsomes derived from human umbilical cord mesenchymal stem cells alleviate Parkinson\u2019s disease and neuronal damage through inhibition of microglia","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"eadl3406","DOI":"10.1126\/sciadv.adl3406","article-title":"The impact of hUC MSC-derived EVsome-nanoliposome hybrids on \u03b1-synuclein fibrillation and neurotoxicity","volume":"10","author":"Aliakbari","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41419-020-2473-5","article-title":"EVsomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"136810","DOI":"10.1016\/j.neulet.2022.136810","article-title":"Mesenchymal stem cell-derived EVsomes altered neuron cholesterol metabolism via Wnt5a-LRP1 axis and alleviated cognitive impairment in a progressive Parkinson\u2019s disease model","volume":"787","author":"Xu","year":"2022","journal-title":"Neurosci. Lett."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tong, B., Ba, Y., Li, Z., Yang, C., Su, K., Qi, H., Zhang, D., Liu, X., Wu, Y., and Chen, Y. (2024). Targeting dysregulated lipid metabolism for the treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease: Current advancements and future prospects. Neurobiol. Dis., 196.","DOI":"10.1016\/j.nbd.2024.106505"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jnen\/nlac037","article-title":"Bone Marrow-Derived Mesenchymal Stem Cell-Derived EVsomes Containing Gli1 Alleviate Microglial Activation and Neuronal Apoptosis In Vitro and in a Mouse Parkinson Disease Model by Direct Inhibition of Sp1 Signaling","volume":"81","author":"Cai","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"137139","DOI":"10.1016\/j.neulet.2023.137139","article-title":"EVsomes rich in Wnt5 improved circadian rhythm dysfunction via enhanced PPAR\u03b3 activity in the 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"802","author":"Li","year":"2023","journal-title":"Neurosci. Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.14336\/AD.2020.1221","article-title":"MSC-Derived EVsomes can Enhance the Angiogenesis of Human Brain MECs and Show Therapeutic Potential in a Mouse Model of Parkinson\u2019s Disease","volume":"12","author":"Xue","year":"2021","journal-title":"Aging Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jnen\/nlac049","article-title":"Bone Marrow Stem Cell-Exo-Derived TSG-6 Attenuates 1-Methyl-4-Phenylpyridinium+-Induced Neurotoxicity via the STAT3\/miR-7\/NEDD4\/LRRK2 Axis","volume":"81","author":"Huang","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1186\/s12967-023-04638-x","article-title":"miR-100a-5p-enriched EVsomes derived from mesenchymal stem cells enhance the anti-oxidant effect in a Parkinson\u2019s disease model via regulation of Nox4\/ROS\/Nrf2 signaling","volume":"21","author":"He","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"137437","DOI":"10.1016\/j.neulet.2023.137437","article-title":"Mesenchymal stem cell EVsomes rich in miR-23b-3p affect the Wnt signaling pathway and promote neuronal autophagy to alleviate PD symptoms","volume":"814","author":"Geng","year":"2023","journal-title":"Neurosci. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.omtn.2021.01.022","article-title":"EVsomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson\u2019s disease","volume":"23","author":"Li","year":"2021","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1007\/s11010-023-04700-8","article-title":"Biochemical study of the effect of mesenchymal stem cells-derived EVsome versus L-Dopa in experimentally induced Parkinson\u2019s disease in rats","volume":"478","author":"Mohamed","year":"2023","journal-title":"Mol. Cell Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"105389","DOI":"10.1016\/j.neuint.2022.105389","article-title":"Inhibition of Wnt\/\u03b2-catenin signaling attenuates axonal degeneration in models of Parkinson\u2019s disease","volume":"159","author":"Huang","year":"2022","journal-title":"Neurochem. Int."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., and Niewiadomska, G. (2020). BDNF as a Promising Therapeutic Agent in Parkinson\u2019s Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031170"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"123014","DOI":"10.1016\/j.lfs.2024.123014","article-title":"Treatment of Parkinson\u2019s disease model with human umbilical cord mesenchymal stem cell-derived EVsomes loaded with BDNF","volume":"356","author":"Wang","year":"2024","journal-title":"Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Zhou, J., Han, Y., and Hou, R. (2023). Potential role of N6-methyladenosine modification in the development of Parkinson\u2019s disease. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1321995"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1186\/s12967-023-04461-4","article-title":"FTO-targeted siRNA delivery by MSC-derived EVsomes synergistically alleviates dopaminergic neuronal death in Parkinson\u2019s disease via m6A-dependent regulation of ATM mRNA","volume":"21","author":"Geng","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","article-title":"Mesenchymal stromal\/stem cell (MSC)-derived EVsomes in clinical trials","volume":"14","author":"Lotfy","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s13287-022-03139-w","article-title":"Priming mesenchymal stem cells with \u03b1-synuclein enhances neuroprotective properties through induction of autophagy in Parkinsonian models","volume":"13","author":"Shin","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Harrell, C.R., Volarevic, A., Djonov, V., and Volarevic, V. (2025). Mesenchymal Stem-Cell-Derived EVsomes as Novel Drug Carriers in Anti-Cancer Treatment: A Myth or Reality?. Cells, 14.","DOI":"10.3390\/cells14030202"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.7150\/thno.62330","article-title":"Engineered EVsomes: Desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies","volume":"11","author":"Xu","year":"2021","journal-title":"Theranostics"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/8\/600\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:15:16Z","timestamp":1760030116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/8\/600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["cells14080600"],"URL":"https:\/\/doi.org\/10.3390\/cells14080600","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}